Continuing challenges and current issues in acute lymphoblastic leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Continuing challenges and current issues in acute lymphoblastic leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 59, Issue 3, Pages 526-541
Publisher
Informa UK Limited
Online
2017-06-12
DOI
10.1080/10428194.2017.1335397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?
- (2016) Mark R. Litzow BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
- (2016) Jae H. Park et al. BLOOD
- Perspectives and Future Directions for Acute Lymphoblastic Leukemia
- (2016) Anjali S. Advani Clinical Lymphoma Myeloma & Leukemia
- Clinical updates in adult acute lymphoblastic leukemia
- (2016) Omar Al Ustwani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- A pooled analysis of long pentraxin for patients with advanced pancreatic cancer.
- (2016) Mitsuhito Sasaki et al. JOURNAL OF CLINICAL ONCOLOGY
- The elephant in the room: Facilitating conversations about advanced cancer between patients and their spouses.
- (2016) Laura S. Porter et al. JOURNAL OF CLINICAL ONCOLOGY
- New monoclonal antibodies for the treatment of acute lymphoblastic leukemia
- (2016) Nosha Farhadfar et al. LEUKEMIA RESEARCH
- Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia
- (2016) Sébastien Maury et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis: a "CHIP" off the old block
- (2015) M. A. Lichtman BLOOD
- FlnA binding to PACSIN2 F-BAR domain regulates membrane tubulation in megakaryocytes and platelets
- (2015) A. J. Begonja et al. BLOOD
- Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia
- (2015) D.-Y. Kim et al. BLOOD
- How I treat acute lymphoblastic leukemia in older adolescents and young adults
- (2015) E. Curran et al. BLOOD
- Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia
- (2015) Y. Chalandon et al. BLOOD
- Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
- (2015) J. J. M. van Dongen et al. BLOOD
- Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
- (2015) N. Dhedin et al. BLOOD
- Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12
- (2015) J. Kuruvilla et al. BLOOD
- New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia
- (2015) Elias Jabbour et al. CANCER
- Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2015) N. Daver et al. HAEMATOLOGICA
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
- (2015) Elias Jabbour et al. LANCET ONCOLOGY
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- Novel immunotherapies in lymphoid malignancies
- (2015) Connie Lee Batlevi et al. Nature Reviews Clinical Oncology
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of Pediatric Acute Lymphoblastic Leukemia
- (2015) Stacy L. Cooper et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2015) N. Daver et al. HAEMATOLOGICA
- Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
- (2015) Kathryn G. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia
- (2014) K. Beldjord et al. BLOOD
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia
- (2014) Max S. Topp et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
- (2014) Dan Douer et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of High-Risk Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia in Adolescents and Adults According to Early Cytologic Response and Minimal Residual Disease After Consolidation Assessed by Flow Cytometry: Final Results of the PETHEMA ALL-AR-03 Trial
- (2014) Josep-Maria Ribera et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
- (2014) D J DeAngelo et al. LEUKEMIA
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
- (2014) K R Schultz et al. LEUKEMIA
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia
- (2014) R Bassan et al. Blood Cancer Journal
- Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia
- (2013) S. Bertoli et al. BLOOD
- Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
- (2013) V. Coelho et al. BLOOD
- UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
- (2013) A. K. Fielding et al. BLOOD
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Overview of clinical flow cytometry data analysis: recent advances and future challenges
- (2013) Carlos E. Pedreira et al. TRENDS IN BIOTECHNOLOGY
- Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis
- (2012) V. Gupta et al. BLOOD
- Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation
- (2012) N. Gokbuget et al. BLOOD
- Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
- (2012) M. S. Topp et al. BLOOD
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
- Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia
- (2012) Wendy Stock et al. CANCER
- Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia
- (2012) H Pfeifer et al. LEUKEMIA
- Blinatumomab: A historical perspective
- (2012) Dirk Nagorsen et al. PHARMACOLOGY & THERAPEUTICS
- Intergroup Trial C10403: A Pediatric Treatment Approach to Improve Outcomes in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
- (2012) Katherine Breitenbach et al. Journal of Adolescent and Young Adult Oncology
- The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review
- (2011) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
- (2011) R. Foa et al. BLOOD
- Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry
- (2011) Ingrid Thörn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia
- (2011) Gunnar Juliusson et al. CANCER
- Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
- (2011) A W Rijneveld et al. LEUKEMIA
- Preclinical Studies on the Mechanism of Action and the Anti-Lymphoma Activity of the Novel Anti-CD20 Antibody GA101
- (2011) S. Dalle et al. MOLECULAR CANCER THERAPEUTICS
- High-Risk Pediatric Acute Lymphoblastic Leukemia: To Transplant or Not to Transplant?
- (2010) Michael A. Pulsipher et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2010) M. Mohty et al. BLOOD
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
- (2010) D. I. Marks et al. BLOOD
- Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
- (2010) S. Soverini et al. HAEMATOLOGICA
- Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group
- (2010) A. Oriol et al. HAEMATOLOGICA
- Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
- (2010) Deborah A. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
- (2009) R. Bassan et al. BLOOD
- Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993
- (2009) Adele K. Fielding et al. BLOOD
- Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
- (2009) Françoise Huguet et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report
- (2009) P S Gaynon et al. LEUKEMIA
- Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients
- (2008) M. A. Sekeres et al. BLOOD
- What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
- (2008) W. Stock et al. BLOOD
- Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century
- (2008) D. Pulte et al. BLOOD
- Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison
- (2008) J. J. Cornelissen et al. BLOOD
- Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96
- (2008) Josep-María Ribera et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute lymphoblastic leukaemia
- (2008) Ching-Hon Pui et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started